H.R. 9336 aims to amend the Social Security Act's Title XIX, which governs the Medicaid program, by requiring states to consider the performance of managed care entities when assigning individuals to these entities. This means that states would need to evaluate how well these care providers deliver services and manage care before making assignments, potentially leading to improved quality of care for Medicaid recipients.
Some media outlets have praised H.R. 9336 for its focus on accountability and quality in Medicaid managed care. Supporters argue that by tying individual assignments to performance metrics, the bill could enhance patient outcomes and ensure that beneficiaries receive care from the most effective providers.
Critics of H.R. 9336 have raised concerns about the potential for increased bureaucracy and administrative burden on states. Some media reports highlight fears that the performance metrics used could be flawed or biased, leading to unfair assignments that do not truly reflect the quality of care provided by managed care entities.
The analysis of H.R. 9336 reveals no direct industry overlaps between the sponsor Craig Goldman’s top donor industries and the bill's subject matter concerning Medicaid managed care entities. The lobbying activity in this policy area shows contributions from various organizations, including the American College of Clinical Pharmacy, which contributed $144,981. However, these contributions do not indicate a direct conflict with the bill's intent. The majority of lobbying amounts are undisclosed, which limits the ability to fully assess potential influences. Overall, the lack of direct industry connections and the minimal financial overlap suggest a low risk of conflict of interest.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AMERICAN COLLEGE OF CLINICAL PHARMACY | AMERICAN COLLEGE OF CLINICAL PHARMACY | $144,981 |
| ALTRIA CLIENT SERVICES | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $40,000 |
| CROHN'S & COLITIS FOUNDATION | CROHN'S & COLITIS FOUNDATION | $40,000 |
| GOTRIANGLE | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $30,000 |
| AFRICAN AMERICAN ALLIANCE OF CDFI CEOS | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $20,000 |
| BRISTOL MYERS SQUIBB | ALEXANDER J. BECKLES, L.L.C. | $20,000 |
| CITY OF GLADEWATER, TEXAS | LONE STAR CONSULTING, LLC | $12,000 |
| CITY OF CRANDALL, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| CITY OF JUSTIN, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | MAGILL ASSOCIATES, LLC | undisclosed |
| OPPORTUNITIES INDUSTRIALIZATION CENTER OF AMERICA, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| LUMBEE TRIBE HOLDINGS, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| CITY OF CLEVELAND, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| CITY OF RIO HONDO, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| HOWARD COUNTY, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Craig Goldman, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
